The 28th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Print

Oral Session

[OR3] Oral Session Ⅲ Cancer②

Thu. Jul 14, 2022 3:30 PM - 4:42 PM Room 3 (3F 304)

Chair persons : Shuji Kubo（Laboratory of Molecular and Genetic Therapeutics, Institute for Advanced Medical Sciences, Hyogo College of Medicine）,Hajime Kurosaki（Division of Molecular Medicine, Department of Genomic Medicine and Regenerative Therapeutics, School of Medicine, Tottori University Faculty of Medicine）

[OR-21] The combination treatment with the adenovirus-mediated REIC/Dkk-3 gene and bevacizumab.

Ryoji Imoto (Department of Neurological Surgery, Okayama University Graduate School)

Abstract password authentication.
The password was sent to all registrants in email. You can also check it in abstracts and a live streamig site.

Password